Literature DB >> 10981107

Compliance, quality of life, and cost effectiveness.

W B Stason.   

Abstract

Mesh：

Substances：

Year:  1999        PMID： 10981107     DOI： 10.1007/s11906-996-0017-8

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN： 1522-6417            Impact factor:   5.369


× No keyword cloud information.
  13 in total

1.  The effects of dietary patterns on quality of life: a substudy of the Dietary Approaches to Stop Hypertension trial.

Authors:  C S Plaisted; P H Lin; J D Ard; M L McClure; L P Svetkey
Journal:  J Am Diet Assoc       Date:  1999-08

2.  Blood-pressure control in the hypertensive population.

Authors:  G Mancia; R Sega; C Milesi; G Cesana; A Zanchetti
Journal:  Lancet       Date:  1997-02-15       Impact factor: 79.321

3.  Effect of initial drug choice on persistence with antihypertensive therapy: the importance of actual practice data.

Authors:  J J Caro; J L Speckman; M Salas; G Raggio; J D Jackson
Journal:  CMAJ       Date:  1999-01-12       Impact factor: 8.262

Review 4.  Quality of life claims in trials of anti-hypertensive therapy.

Authors:  S M Hunt
Journal:  Qual Life Res       Date:  1997-03       Impact factor: 4.147

5.  Variations in compliance among hypertensive patients by drug class: implications for health care costs.

Authors:  J A Rizzo; W R Simons
Journal:  Clin Ther       Date:  1997 Nov-Dec       Impact factor: 3.393

6.  Long-term cost-effectiveness of various initial monotherapies for mild to moderate hypertension.

Authors:  J T Edelson; M C Weinstein; A N Tosteson; L Williams; T H Lee; L Goldman
Journal:  JAMA       Date:  1990-01-19       Impact factor: 56.272

Review 7.  Actual blood pressure control: are we doing things right?

Authors:  A Coca
Journal:  J Hypertens Suppl       Date:  1998-01

8.  Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991.

Authors:  V L Burt; P Whelton; E J Roccella; C Brown; J A Cutler; M Higgins; M J Horan; D Labarthe
Journal:  Hypertension       Date:  1995-03       Impact factor: 10.190

Review 9.  The rationale for combination versus single-entity therapy in hypertension.

Authors:  M R Weir
Journal:  Am J Hypertens       Date:  1998-10       Impact factor: 2.689

Review 10.  What are the implications for the community of the discrepancy between the theory and practice of BP control?

Authors:  R Jackson
Journal:  J Hum Hypertens       Date:  1995-07       Impact factor: 3.012
View more
  4 in total

1.  Development of new concepts of non-adherence measurements among users of antihypertensives medicines.

Authors:  Lene Juel Kjeldsen; Lars Bjerrum; Hanne Herborg; Pia Knudsen; Charlotte Rossing; Birthe Søndergaard
Journal:  Int J Clin Pharm       Date:  2011-04-28

2.  Pharmacoeconomics of antihypertensive drug treatment: an analysis of how long patients remain on various antihypertensive therapies.

Authors:  Luca Degli Esposti; Mirko Di Martino; Stefania Saragoni; Andrea Sgreccia; Alessandro Capone; Stefano Buda; Ezio Degli Esposti
Journal:  J Clin Hypertens (Greenwich)       Date:  2004-02       Impact factor: 3.738

3.  Changes in the continuation of antihypertensive drug use after ALLHAT.

Authors:  Fagen Xie; Diana B Petitti; Joel Handler
Journal:  J Clin Hypertens (Greenwich)       Date:  2005-11       Impact factor: 3.738

4.  Developing a generic, individualised adherence programme for chronic medication users.

Authors:  Hanne Herborg; Lotte S Haugbølle; Lene Sørensen; Charlotte Rossing; Pernille Dam
Journal:  Pharm Pract (Granada)       Date:  2008-09-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.